| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |